Elevian develops regenerative medicines that target root-cause aging mechanisms. Elevian’s founders have identified blood factors that regulate aging and stimulate the body’s natural repair and regeneration mechanisms. By targeting root-cause aging mechanisms, Elevian's therapeutics have the potential to treat or prevent multiple degenerative diseases and extend healthy lifespan.

Key People: 

Founded:              2017

Headquarters:   Boston, Massachusetts